Sun Pharmaceutical Industries Ltd on Wednesday said it along with its US-based arm Ranbaxy, Inc, has signed a $485 million settlement with two plaintiff groups regarding Ranbaxy generic drug application antitrust litigation.
The company and its arm have signed a binding term sheet with two plaintiff groups, the Direct Purchaser and End-Payor Plaintiffs, collectively resolving all of the claims against the company, in the matter of "In re Ranbaxy Generic Drug Application Antitrust Litigation", Sun Pharma said in a regulatory filing.
The case has been ongoing in the US District Court for the District of Massachusetts (USA) for several years, it added. There were multiple antitrust, consumer protection, and civil RICO class actions consolidated in the District of Massachusetts, (USA) against the Company in connection with generic Diovan, a drug for the treatment of hypertension; generic Nexium, a drug for the treatment of gastroesophageal reflux disease and peptic ulcers; and generic Valcyte, a drug for the treatment of cytomegalovirus disease, it added.
Also Read:
The actions and claims relating to alleged conduct by Ranbaxy Laboratories Ltd. and its US subsidiary prior to its acquisition by Sun Pharmaceutical Industries Ltd, the company said. Sun Pharma said has disputed the claims of the plaintiffs and defended these matters vigorously.
"With a view to resolve this dispute and avoid uncertainty, the company has agreed to enter a comprehensive settlement with these plaintiff groups for a total settlement amount of $485 million," it said.
As a consequence of the binding term sheet, the company shall execute the necessary settlement agreements, which, upon approval by the US Court, will ensure that all allegations against it has denied, is "not conceded and not admitted, do not survive and stand extinguished".
(Edited by : Jomy Jos Pullokaran)
First Published: Mar 23, 2022 11:01 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
PM Modi, Rahul Gandhi election rallies in Delhi today: Here are the routes to avoid
May 18, 2024 11:28 AM
Celebrity Kangana vs 'royal' Vikramaditya on Himachal's Mandi seat: Clash of richest titans
May 18, 2024 11:11 AM
2024 Lok Sabha Elections | Will Amethi and Rae Bareli see the rise of Priyanka Gandhi as a dominant political figure
May 18, 2024 8:59 AM
Lok Sabha Election 2024: I.N.D.I.A. bloc to hold rally at Mumbai's BKC today
May 17, 2024 5:18 PM